Guichun Huang

2.1k total citations
53 papers, 1.7k citations indexed

About

Guichun Huang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Guichun Huang has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 26 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Guichun Huang's work include Cancer, Hypoxia, and Metabolism (13 papers), Epigenetics and DNA Methylation (8 papers) and Angiogenesis and VEGF in Cancer (7 papers). Guichun Huang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (13 papers), Epigenetics and DNA Methylation (8 papers) and Angiogenesis and VEGF in Cancer (7 papers). Guichun Huang collaborates with scholars based in China, Sweden and United States. Guichun Huang's co-authors include Longbang Chen, Haizhu Song, Leilei Tao, Yitian Chen, Rui Wang, Jun Yi, Yitian Chen, Xiaoyuan Chu, Jinghua Wang and Yun Zheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Guichun Huang

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guichun Huang China 24 959 655 636 279 239 53 1.7k
Bin Shi China 10 1.2k 1.2× 852 1.3× 606 1.0× 219 0.8× 271 1.1× 16 2.1k
Chongbiao Huang China 26 824 0.9× 765 1.2× 598 0.9× 439 1.6× 261 1.1× 49 1.7k
Marc D. Bullock United Kingdom 21 1.2k 1.3× 475 0.7× 934 1.5× 195 0.7× 185 0.8× 30 1.8k
Chuanyuan Wei China 19 1.1k 1.2× 343 0.5× 729 1.1× 261 0.9× 241 1.0× 52 1.6k
Shujun Cheng China 24 1.1k 1.2× 489 0.7× 651 1.0× 186 0.7× 294 1.2× 80 1.8k
Silvestre Vicent Spain 24 1.1k 1.2× 721 1.1× 411 0.6× 361 1.3× 477 2.0× 40 2.0k
Sharrell Lee United States 6 1.1k 1.1× 994 1.5× 597 0.9× 239 0.9× 201 0.8× 9 1.8k
David Nittner Belgium 13 1.1k 1.1× 753 1.1× 657 1.0× 490 1.8× 264 1.1× 18 1.7k
Jianjie Zhu China 25 1.1k 1.1× 864 1.3× 713 1.1× 526 1.9× 437 1.8× 63 2.1k
Chandramu Chetty United States 24 923 1.0× 451 0.7× 730 1.1× 154 0.6× 148 0.6× 32 1.6k

Countries citing papers authored by Guichun Huang

Since Specialization
Citations

This map shows the geographic impact of Guichun Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guichun Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guichun Huang more than expected).

Fields of papers citing papers by Guichun Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guichun Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guichun Huang. The network helps show where Guichun Huang may publish in the future.

Co-authorship network of co-authors of Guichun Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Guichun Huang. A scholar is included among the top collaborators of Guichun Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guichun Huang. Guichun Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Ying, Zhiyong Zhang, Fan Pan, et al.. (2024). Pericytes recruited by CCL28 promote vascular normalization after anti-angiogenesis therapy through RA/RXRA/ANGPT1 pathway in lung adenocarcinoma. Journal of Experimental & Clinical Cancer Research. 43(1). 210–210. 4 indexed citations
3.
Xie, Sisi, Ying Ye, Xiaoting Sun, et al.. (2022). Dietary ketone body–escalated histone acetylation in megakaryocytes alleviates chemotherapy-induced thrombocytopenia. Science Translational Medicine. 14(673). eabn9061–eabn9061. 9 indexed citations
4.
Ye, Ying, Sisi Xie, Yintao Li, et al.. (2021). Megakaryocytes Mediate Hyperglycemia-Induced Tumor Metastasis. Cancer Research. 81(21). 5506–5522. 22 indexed citations
5.
Sun, Qian, Kai Zhang, Huan Li, et al.. (2020). The overexpression of maspin increases the sensitivity of lung adenocarcinoma drug-resistant cells to docetaxel in vitro and in vivo. Annals of Translational Medicine. 8(22). 1522–1522. 3 indexed citations
6.
Tao, Leilei, Guichun Huang, Yitian Chen, & Longbang Chen. (2015). DNA Methylation of DKK3 Modulates Docetaxel Chemoresistance in Human Nonsmall Cell Lung Cancer Cell. Cancer Biotherapy and Radiopharmaceuticals. 30(2). 100–106. 22 indexed citations
7.
Zhang, Wenwen, Jing Xu, Wei Song, et al.. (2014). TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer. Oncotarget. 6(5). 3003–3012. 20 indexed citations
8.
Ren, Jin, Rui Wang, Haizhu Song, Guichun Huang, & Longbang Chen. (2014). Secreted Frizzled Related Protein 1 Modulates Taxane Resistance of Human Lung Adenocarcinoma. Molecular Medicine. 20(1). 164–178. 20 indexed citations
9.
Lai, Jing, Fang Yang, Wenwen Zhang, et al.. (2014). TAp73 and ΔNp73 Have Opposing Roles in 5-aza-2′-Deoxycytidine-Induced Apoptosis in Breast Cancer Cells. Molecules and Cells. 37(8). 605–612. 11 indexed citations
10.
Ren, Jin, Rui Wang, Guichun Huang, et al.. (2013). sFRP1 Inhibits Epithelial–Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cell Line. Cancer Biotherapy and Radiopharmaceuticals. 28(7). 565–571. 28 indexed citations
11.
Wang, Zexing, et al.. (2013). Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk. Tumor Biology. 35(4). 3035–3039. 7 indexed citations
13.
14.
Wang, Zexing, et al.. (2013). Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. 70(2). 225–231. 48 indexed citations
15.
Chen, Jing, Xiang Huang, Guichun Huang, et al.. (2012). Preconditioning Chemotherapy with Cisplatin Enhances the Antitumor Activity of Cytokine-Induced Killer Cells in a Murine Melanoma Model. Cancer Biotherapy and Radiopharmaceuticals. 27(3). 210–220. 40 indexed citations
16.
Huang, Guichun, Jian Geng, Rui Wang, & Longbang Chen. (2012). Identification of a New Cytotoxic T-Cell Epitope p675 of Human Telomerase Reverse Transcriptase. Cancer Biotherapy and Radiopharmaceuticals. 27(9). 600–605. 3 indexed citations
17.
Huang, Guichun. (2010). Improved analysis for the benchmark system of an active power filter. 29. 640–644. 1 indexed citations
18.
Huang, Guichun & Longbang Chen. (2009). Discrepancies Between Antiangiogenic and Antitumor Effects of Recombinant Human Endostatin. Cancer Biotherapy and Radiopharmaceuticals. 24(5). 589–596. 8 indexed citations
19.
Huang, Guichun & Longbang Chen. (2008). Review : Tumor Vasculature and Microenvironment Normalization: A Possible Mechanism of Antiangiogenesis Therapy. Cancer Biotherapy and Radiopharmaceuticals. 23(5). 661–668. 23 indexed citations
20.
Geng, Jian, Youwei Zhang, Guichun Huang, & Longbang Chen. (2008). XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis. World Journal of Gastroenterology. 14(43). 6733–6733. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026